High-Dose Chemotherapy with Blood or Bone Marrow Transplants for Rhabdomyosarcoma

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 4, 2010, Pages 525-532

  Stiff, Patrick J ^a   Agovi, Manza A ^b   Antman, Karen H ^c   Blaise, Didier ^d   Camitta, Bruce M ^e   Cairo, Mitchell S ^f   Childs, Richard W ^g   Edwards, John R ^h   Gale, Robert Peter ⁱ   Hale, Gregory A ^j   Lazarus, Hillard M ^k   Arora, Mukta ^l  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c BOSTON UNIVERSITY   (United States)

^d INSTITUT PAOLI CALMETTES   (France)

^e Columbia University Medical Center ^*  (United States)

^f NewYork Presbyterian Hospital   (United States)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

^h FLORIDA HOSPITAL CANCER INSTITUTE   (United States)

ⁱ CELGENE CORPORATION   (United States)

^j JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

^k UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^l UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4BETA7 INTEGRIN; CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; INTEGRIN; MELPHALAN; MITOXANTRONE; PACLITAXEL; THIOTEPA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLOOD AUTOTRANSFUSION; CANCER REGRESSION; CANCER RELAPSE; CHILD; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RHABDOMYOSARCOMA; TREATMENT RESPONSE; BONE MARROW TRANSPLANTATION; DISEASE FREE SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; PRESCHOOL CHILD; PROCEDURES; PROGNOSIS; RISK FACTOR; SURVIVAL; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; PROGNOSIS; RHABDOMYOSARCOMA; RISK FACTORS; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77649340936     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.11.020     Document Type: Article

References (20)

1. Pappo A.S., Shapiro D.N., Crist W.M., and Maurer H.M. Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol 13 (1995) 2123-2139
2. Crist W.M., Garnsey L., Beltangady M.S., et al. Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee. J Clin Oncol 8 (1990) 443-452
3. Rodary C., Gehan E.A., Flamant F., et al. Prognostic factors in 951 nonmetastatic rhabdomyosarcoma in children: a report from the International Rhabdomyosarcoma Workshop. Med Pediatr Oncol 19 (1991) 89-95
4. Breitfeld P.P., and Meyer W.H. Rhabdomyosarcoma: new windows of opportunity. Oncologist 10 (2005) 518-527
5. Carli M., Colombatti R., Oberlin O., et al. High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma. J Clin Oncol 17 (1999) 2796-2803
6. Boulad F., Kernan N.A., LaQuaglia M.P., et al. High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma. J Clin Oncol 16 (1998) 1697-1706
7. Horowitz M.E., Kinsella T.J., Wexler L.H., et al. Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma. J Clin Oncol 11 (1993) 1911-1918
8. Pappo A.S., Anderson J.R., Crist W.M., et al. Survival after relapse in children and adolescents with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol 17 (1999) 3487-3493
9. Koscielniak E., Rosta G., Hartmann O., et al. High dose chemotherapy (HDC) with hematopoietic rescue (HR) in patients iwth rhabdomyosarcoma (RMS): an EBMT Solid Tumor Working party survey. Bone Marrow Transplant 19 (1997) S86
10. Klein J.P., and Moeschberger J.L. Survival analysis. Techniques for Censored and Truncated Data (1997), Springer Science, New York, NY 334-336
11. Gooley T.A., Leisenring W., Crowley J., and Storer B.E. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18 (1999) 695-706
12. Kaplan E. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
13. Weigel B.J., Breitfeld P.P., Hawkins D., Crist W.M., and Baker K.S. Role of high-dose chemotherapy with hematopoietic stem cell rescue in the treatment of metastatic or recurrent rhabdomyosarcoma. J Pediatr Hematol Oncol 23 (2001) 272-276
14. Clark M.A., Fisher C., Judson I., and Thomas J.M. Soft-tissue sarcomas in adults. N Engl J Med 353 (2005) 701-711
15. Breneman J.C., Lyden E., Pappo A.S., et al. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma-a report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 21 (2003) 78-84
16. Carli M., Colombatti R., Oberlin O., et al. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors. J Clin Oncol 22 (2004) 4787-4794
17. Lager J.J., Lyden E.R., Anderson J.R., Pappo A.S., Meyer W.H., and Breitfeld P.P. Pooled analysis of phase II window studies in children with contemporary high-risk metastatic rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. J Clin Oncol 24 (2006) 3415-3422
18. Dantonello T.M., Int-Veen C., Winkler P., et al. Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma. J Clin Oncol 26 (2008) 406-413
19. Meyers P.A. High-dose therapy with autologous stem cell rescue for pediatric sarcomas. Curr Opin Oncol 16 (2004) 120-125
20. Koscielniak E., Klingebiel T.H., Peters C., et al. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group. Bone Marrow Transplant 19 (1997) 227-231